购物车
- 全部删除
- 您的购物车当前为空
JMV 2959 is an antagonist of growth hormone secretagogue receptor type 1a (GHS-R1a) (IC50: 32 nM).
JMV 2959 is an antagonist of growth hormone secretagogue receptor type 1a (GHS-R1a) (IC50: 32 nM).
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
2 mg | ¥ 642 | 5日内发货 | |
5 mg | ¥ 1,080 | 5日内发货 | |
25 mg | ¥ 4,280 | 6-8周 | |
50 mg | ¥ 5,570 | 6-8周 | |
100 mg | ¥ 8,950 | 6-8周 | |
1 mL x 10 mM (in DMSO) | ¥ 1,350 | 5日内发货 |
产品描述 | JMV 2959 is an antagonist of growth hormone secretagogue receptor type 1a (GHS-R1a) (IC50: 32 nM). |
靶点活性 | GHS-R1a:32 nM |
体外活性 | JMV 2959 does not cause any intracellular calcium mobilization by itself[1]. |
体内活性 | JMV 2959 dose-dependently reduces the startle response (F(3.42)=4.4, p<0.01) and enhances prepulse inhibition (PPI) (F(3.42)=3.9, p<0.05) in the prepulse inhibition paradigm. JMV 2959 (6 mg/kg) causes a obviously suppression of locomotion on days 1 to 7 relative to baseline day 0 (F(7,49)=2.21, p<0.05). When administered alone, it does not increase food intake and does not obviously stimulate growth hormone (GH) release[1]. The alteration in the startle response is mainly due to a 27% decrease in the startle seen in the highest dose of JMV 2959 (6 mg/kg) compare to vehicle (p<0.05)[2]. Results also reveal a significant interaction between JMV 2959 treatment and day (F(1,14)=4.397, p<0.05)[3]. |
分子量 | 508.61 |
分子式 | C30H32N6O2 |
CAS No. | 925238-89-7 |
密度 | no data available |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容